Axa S.A. Cabaletta Bio, Inc. Transaction History

Axa S.A.

$29.5 Billion
Q1 2025

A detailed history of Axa S.A. transactions in Cabaletta Bio, Inc. stock. As of the latest transaction made, Axa S.A. holds 270,077 shares of CABA stock, worth $378,107. This represents 0.0% of its overall portfolio holdings.

Number of Shares

270,077

Previous 270,423 0.13%

Holding current value

$378,107

Previous $594,000 36.87%

% of portfolio

0.0%

Previous 0.0%

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$1.39 - $2.74 $480 - $948	-346 Reduced 0.13%	270,077 $375,000
Q4 2024 Feb 14, 2025	SELL	$1.87 - $4.91 $805 - $2,116	-431 Reduced 0.16%	270,423 $594,000
Q3 2024 Nov 14, 2024	BUY	$3.94 - $8.24 $299 - $626	76 Added 0.03%	270,854 $1.28 Million
Q2 2024 Feb 25, 2025	BUY	$7.22 - $18.82 $2,563 - $6,681	355 Added 0.13%	270,778 $2.03 Million
Q2 2024 Aug 14, 2024	BUY	$7.22 - $18.82 $668,687 - $1.74 Million	92,616 Added 51.98%	270,778 $2.03 Million
Q1 2024 May 15, 2024	BUY	$16.79 - $25.38 $2.99 Million - $4.52 Million	178,162 New	178,162 $3.04 Million

Others Institutions Holding CABA

# of Institutions

Shares Held

41.2M

Call Options Held

154K

Put Options Held

192K

View Full List

About Cabaletta Bio, Inc.

Ticker CABA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,014,000
Market Cap $40.6M
Description
Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...

More about CABA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

News

Stay updated on Axa S.A. with notifications on news.

Account